Abbott Q1 revenues up 30%; non-GAAP EPS up 17%; shares up 2% premarket

|About: Abbott Laboratories (ABT)|By:, SA News Editor

Abbott (ABT +0.3%) Q1 results: Revenues: $6,335M (+29.7%); Nutrition: $1,642M (-1.7%); Diagnostics: $1,158M (+3.6%); Established Pharmaceuticals: $950M (+7.0%); Medical Devices: $2,395M (+100.2%).

Operating Loss: ($202M) (-138.5%); Net Income: $386M; EPS: $0.22; Non-GAAP EPS: $0.48 (+17.1%).

2017 Guidance: EPS: $0.92 - 1.02 (unch); Non-GAAP EPS: $2.40 - 2.50 (unch).

Shares are up 2% premarket on light volume.